United States Pharmaceuticals

Colucid Pharmaceuticals Inc (CLCD)

Track

Ticker: CLCD Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hogan Linda C. Head, Bus. Dev. and Strategy
Transaction date
Planned sale
Price
369.90
Quantity 43,091 -42.3%
Value US$3,892,234
Hogan Linda C. Head, Bus. Dev. and Strategy
Transaction date
Planned sale
Price
379.10
Quantity 7,359 +15.9%
Value US$3,340,270
Hogan Linda C. Head, Bus. Dev. and Strategy
Transaction date
Planned sale
Price
387.01
Quantity 26,467 -11.5%
Value US$1,313,718
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.60
Quantity 500 -0.2%
Value US$17,800
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.86
Quantity 200 -0.1%
Value US$6,972
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.25
Quantity 802 -0.3%
Value US$27,465
Hogan Linda C. Head, Bus. Dev. and Strategy
Transaction date
Planned sale
Price
36.40
Quantity 185 -100.0%
Value US$6,734
Hogan Linda C. Head, Bus. Dev. and Strategy
Transaction date
Planned sale
Price
36.25
Quantity 718 -100.0%
Value US$26,028
Kuca Bernice Head,Clin. and Reg. Operations
Transaction date
Planned sale
Price
36.25
Quantity 772 -1.9%
Value US$27,985
Dallas Matthew D Chief Financial Officer
Transaction date
Planned sale
Price
36.25
Quantity 1,473 -3.5%
Value US$53,396
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
38.75
Quantity 1,502 -0.6%
Value US$58,202
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
38.75
Quantity 1,678 -100.0%
Value US$65,022
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
38.75
Quantity 186 -100.0%
Value US$7,208
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
35.22
Quantity 719 -100.0%
Value US$25,323
Kuca Bernice Head,Clin. and Reg. Operations Officer
Transaction date
Planned sale
Price
35.22
Quantity 772 -1.9%
Value US$27,190
Dallas Matthew D Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.17
Quantity 1,473 -3.4%
Value US$51,801
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
28.52
Quantity 1,677 -100.0%
Value US$47,830
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.57
Quantity 1,502 -0.6%
Value US$42,917
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
28.95
Quantity 185 -100.0%
Value US$5,356
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
30.00
Quantity 719 -100.0%
Value US$21,570
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
37.08
Quantity 1,502 -0.6%
Value US$55,694
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
37.08
Quantity 1,677 -100.0%
Value US$62,183
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
36.41
Quantity 185 -100.0%
Value US$6,736
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
37.74
Quantity 719 -100.0%
Value US$27,135
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
23.78
Quantity 300 -0.1%
Value US$7,134
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
23.30
Quantity 5,700 -2.3%
Value US$132,812
Novo A/S Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 100,000 +3.3%
Value US$2,000,000
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
24.40
Quantity 300 -0.1%
Value US$7,319
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
23.43
Quantity 442 -0.2%
Value US$10,355
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
22.62
Quantity 2,633 -1.0%
Value US$59,549
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
21.90
Quantity 962 -0.4%
Value US$21,072
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.56
Quantity 663 -0.3%
Value US$13,628
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
19.50
Quantity 1,502 -0.6%
Value US$29,289
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
19.50
Quantity 3,735 -100.0%
Value US$72,832
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
20.00
Quantity 31,420 -100.0%
Value US$628,435
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
20.00
Quantity 5,032 -13.8%
Value US$100,640
Hogan Linda C. Head, Bus. Dev. and Strategy Officer
Transaction date
Planned sale
Price
19.50
Quantity 8,549 -19.0%
Value US$166,706
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
10.86
Quantity 150 -76.1%
Value US$1,629
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
8.41
Quantity 508 -72.1%
Value US$4,272
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
8.30
Quantity 508 -41.9%
Value US$4,216
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
8.31
Quantity 1,502 -0.6%
Value US$12,482
DP VI Associates, L.P. Large shareholder
Transaction date
Sale
Price
8.15
Quantity 129 -4.1%
Value US$1,051
Domain Partners VI, L.P. Large shareholder
Transaction date
Sale
Price
8.15
Quantity 81,094 -4.0%
Value US$660,916
DP VI Associates, L.P. Large shareholder
Transaction date
Sale
Price
8.71
Quantity 32 -1.0%
Value US$279
Domain Partners VI, L.P. Large shareholder
Transaction date
Sale
Price
8.71
Quantity 19,718 -1.0%
Value US$171,744
DP VI Associates, L.P. Large shareholder
Transaction date
Sale
Price
8.82
Quantity 84 -2.6%
Value US$741
Domain Partners VI, L.P. Large shareholder
Transaction date
Sale
Price
8.82
Quantity 52,216 -2.5%
Value US$460,545
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
9.09
Quantity 508 -29.5%
Value US$4,615
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
8.97
Quantity 508 -22.8%
Value US$4,557
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
9.10
Quantity 508 -18.6%
Value US$4,623
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
9.73
Quantity 1,502 -0.6%
Value US$14,614
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
7.01
Quantity 516 -15.9%
Value US$3,618
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
7.00
Quantity 500 -13.3%
Value US$3,500
Skwierczynski Raymond Head,Pharmaceutical Operations Officer
Transaction date
Planned sale
Price
6.60
Quantity 508 -11.9%
Value US$3,352
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
7.25
Quantity 1,502 -0.6%
Value US$10,884
DP VI Associates, L.P. Large shareholder
Transaction date
Sale
Price
6.96
Quantity 235 -6.7%
Value US$1,636
Domain Partners VI, L.P. Large shareholder
Transaction date
Sale
Price
6.96
Quantity 149,765 -6.7%
Value US$1,042,364
Mathers Thomas P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
7.10
Quantity 7,500 +inf%
Value US$53,275
Novo A/S Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 1,300,000 +74.0%
Value US$13,000,000
Marengere Luc Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 500,000 +50.2%
Value US$5,000,000
PAPPAS ARTHUR M Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 17,560 +17.8%
Value US$175,600
PAPPAS ARTHUR M Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 282,440 +17.8%
Value US$2,824,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-01-05 2017-01-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
43,091 -42.3%
369.90
US$3,892,234 		43,091 -42.3% 369.90 US$3,892,234
2017-01-05 2017-01-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
7,359 +15.9%
379.10
US$3,340,270 		7,359 +15.9% 379.10 US$3,340,270
2017-01-05 2017-01-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
26,467 -11.5%
387.01
US$1,313,718 		26,467 -11.5% 387.01 US$1,313,718
2017-01-05 2017-01-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
500 -0.2%
35.60
US$17,800 		500 -0.2% 35.60 US$17,800
2017-01-05 2017-01-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
200 -0.1%
34.86
US$6,972 		200 -0.1% 34.86 US$6,972
2017-01-05 2017-01-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
802 -0.3%
34.25
US$27,465 		802 -0.3% 34.25 US$27,465
2017-01-05 2017-01-04 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
185 -100.0%
36.40
US$6,734 		185 -100.0% 36.40 US$6,734
2017-01-05 2017-01-03 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy
718 -100.0%
36.25
US$26,028 		718 -100.0% 36.25 US$26,028
2017-01-04 2017-01-03 PlS Planned sale Kuca Bernice

Head,Clin. and Reg. Operations
772 -1.9%
36.25
US$27,985 		772 -1.9% 36.25 US$27,985
2017-01-04 2017-01-03 PlS Planned sale Dallas Matthew D

Chief Financial Officer
1,473 -3.5%
36.25
US$53,396 		1,473 -3.5% 36.25 US$53,396
2016-12-05 2016-12-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
38.75
US$58,202 		1,502 -0.6% 38.75 US$58,202
2016-12-05 2016-12-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
1,678 -100.0%
38.75
US$65,022 		1,678 -100.0% 38.75 US$65,022
2016-12-05 2016-12-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
186 -100.0%
38.75
US$7,208 		186 -100.0% 38.75 US$7,208
2016-12-05 2016-12-01 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
719 -100.0%
35.22
US$25,323 		719 -100.0% 35.22 US$25,323
2016-12-01 2016-12-01 PlS Planned sale Kuca Bernice

Head,Clin. and Reg. Operations

Officer
772 -1.9%
35.22
US$27,190 		772 -1.9% 35.22 US$27,190
2016-12-01 2016-12-01 PlS Planned sale Dallas Matthew D

Chief Financial Officer

Officer
1,473 -3.4%
35.17
US$51,801 		1,473 -3.4% 35.17 US$51,801
2016-11-07 2016-11-07 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
1,677 -100.0%
28.52
US$47,830 		1,677 -100.0% 28.52 US$47,830
2016-11-07 2016-11-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
28.57
US$42,917 		1,502 -0.6% 28.57 US$42,917
2016-11-07 2016-11-04 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
185 -100.0%
28.95
US$5,356 		185 -100.0% 28.95 US$5,356
2016-11-01 2016-11-01 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
719 -100.0%
30.00
US$21,570 		719 -100.0% 30.00 US$21,570
2016-10-05 2016-10-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
37.08
US$55,694 		1,502 -0.6% 37.08 US$55,694
2016-10-05 2016-10-05 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
1,677 -100.0%
37.08
US$62,183 		1,677 -100.0% 37.08 US$62,183
2016-10-05 2016-10-04 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
185 -100.0%
36.41
US$6,736 		185 -100.0% 36.41 US$6,736
2016-10-05 2016-10-03 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
719 -100.0%
37.74
US$27,135 		719 -100.0% 37.74 US$27,135
2016-09-16 2016-09-14 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
300 -0.1%
23.78
US$7,134 		300 -0.1% 23.78 US$7,134
2016-09-16 2016-09-14 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
5,700 -2.3%
23.30
US$132,812 		5,700 -2.3% 23.30 US$132,812
2016-09-13 2016-09-09 B Purchase Novo A/S Large shareholder
100,000 +3.3%
20.00
US$2,000,000 		100,000 +3.3% 20.00 US$2,000,000
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
300 -0.1%
24.40
US$7,319 		300 -0.1% 24.40 US$7,319
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
442 -0.2%
23.43
US$10,355 		442 -0.2% 23.43 US$10,355
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
2,633 -1.0%
22.62
US$59,549 		2,633 -1.0% 22.62 US$59,549
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
962 -0.4%
21.90
US$21,072 		962 -0.4% 21.90 US$21,072
2016-09-07 2016-09-07 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
663 -0.3%
20.56
US$13,628 		663 -0.3% 20.56 US$13,628
2016-09-07 2016-09-06 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
19.50
US$29,289 		1,502 -0.6% 19.50 US$29,289
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
3,735 -100.0%
19.50
US$72,832 		3,735 -100.0% 19.50 US$72,832
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
31,420 -100.0%
20.00
US$628,435 		31,420 -100.0% 20.00 US$628,435
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
5,032 -13.8%
20.00
US$100,640 		5,032 -13.8% 20.00 US$100,640
2016-09-07 2016-09-06 PlS Planned sale Hogan Linda C.

Head, Bus. Dev. and Strategy

Officer
8,549 -19.0%
19.50
US$166,706 		8,549 -19.0% 19.50 US$166,706
2016-08-31 2016-08-31 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
150 -76.1%
10.86
US$1,629 		150 -76.1% 10.86 US$1,629
2016-08-19 2016-08-19 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -72.1%
8.41
US$4,272 		508 -72.1% 8.41 US$4,272
2016-08-10 2016-08-10 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -41.9%
8.30
US$4,216 		508 -41.9% 8.30 US$4,216
2016-08-05 2016-08-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
8.31
US$12,482 		1,502 -0.6% 8.31 US$12,482
2016-08-03 2016-08-03 S Sale DP VI Associates, L.P. Large shareholder
129 -4.1%
8.15
US$1,051 		129 -4.1% 8.15 US$1,051
2016-08-03 2016-08-03 S Sale Domain Partners VI, L.P. Large shareholder
81,094 -4.0%
8.15
US$660,916 		81,094 -4.0% 8.15 US$660,916
2016-08-03 2016-08-02 S Sale DP VI Associates, L.P. Large shareholder
32 -1.0%
8.71
US$279 		32 -1.0% 8.71 US$279
2016-08-03 2016-08-02 S Sale Domain Partners VI, L.P. Large shareholder
19,718 -1.0%
8.71
US$171,744 		19,718 -1.0% 8.71 US$171,744
2016-08-03 2016-08-01 S Sale DP VI Associates, L.P. Large shareholder
84 -2.6%
8.82
US$741 		84 -2.6% 8.82 US$741
2016-08-03 2016-08-01 S Sale Domain Partners VI, L.P. Large shareholder
52,216 -2.5%
8.82
US$460,545 		52,216 -2.5% 8.82 US$460,545
2016-07-29 2016-07-29 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -29.5%
9.09
US$4,615 		508 -29.5% 9.09 US$4,615
2016-07-20 2016-07-20 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -22.8%
8.97
US$4,557 		508 -22.8% 8.97 US$4,557
2016-07-12 2016-07-11 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -18.6%
9.10
US$4,623 		508 -18.6% 9.10 US$4,623
2016-07-05 2016-07-05 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
9.73
US$14,614 		1,502 -0.6% 9.73 US$14,614
2016-06-30 2016-06-30 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
516 -15.9%
7.01
US$3,618 		516 -15.9% 7.01 US$3,618
2016-06-22 2016-06-20 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
500 -13.3%
7.00
US$3,500 		500 -13.3% 7.00 US$3,500
2016-06-22 2016-06-10 PlS Planned sale Skwierczynski Raymond

Head,Pharmaceutical Operations

Officer
508 -11.9%
6.60
US$3,352 		508 -11.9% 6.60 US$3,352
2016-06-07 2016-06-06 PlS Planned sale Mathers Thomas P.

Chief Executive Officer

Executive Director
1,502 -0.6%
7.25
US$10,884 		1,502 -0.6% 7.25 US$10,884
2016-05-02 2016-04-28 S Sale DP VI Associates, L.P. Large shareholder
235 -6.7%
6.96
US$1,636 		235 -6.7% 6.96 US$1,636
2016-05-02 2016-04-28 S Sale Domain Partners VI, L.P. Large shareholder
149,765 -6.7%
6.96
US$1,042,364 		149,765 -6.7% 6.96 US$1,042,364
2015-08-25 2015-08-25 B Purchase Mathers Thomas P.

Chief Executive Officer

Executive Director
7,500 +inf%
7.10
US$53,275 		7,500 +inf% 7.10 US$53,275
2015-05-12 2015-05-11 B Purchase Novo A/S Large shareholder
1,300,000 +74.0%
10.00
US$13,000,000 		1,300,000 +74.0% 10.00 US$13,000,000
2015-05-12 2015-05-11 B Purchase Marengere Luc Non-Executive Director Large shareholder
500,000 +50.2%
10.00
US$5,000,000 		500,000 +50.2% 10.00 US$5,000,000
2015-05-12 2015-05-11 B Purchase PAPPAS ARTHUR M Non-Executive Director Large shareholder
17,560 +17.8%
10.00
US$175,600 		17,560 +17.8% 10.00 US$175,600
2015-05-12 2015-05-11 B Purchase PAPPAS ARTHUR M Non-Executive Director Large shareholder
282,440 +17.8%
10.00
US$2,824,400 		282,440 +17.8% 10.00 US$2,824,400
Explore more

More insider trading research around Colucid Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America